BAR-1 is a protein playing a pivotal role within the Wnt signaling pathway in the organism Caenorhabditis elegans, which serves as a valuable model for understanding fundamental biological processes. As a homolog to the mammalian β-catenin, BAR-1 is a transcriptional co-activator that is essential for the regulation of gene expression during development and cellular differentiation. The Wnt pathway itself is highly conserved and intricately involved in the regulation of cell fate, proliferation, and polarity. Within this pathway, BAR-1's primary function is to mediate the transcription of Wnt target genes by entering the nucleus and engaging with transcription factors. The proper functioning and regulation of this pathway are crucial for normal organismal development and cellular homeostasis.
The expression of BAR-1 can be influenced by a variety of chemical compounds, which exert their effects by interacting with the components of the Wnt signaling pathway. For example, compounds such as Lithium chloride can inhibit GSK-3β, a kinase responsible for the phosphorylation and subsequent degradation of β-catenin homologs, leading to the accumulation and increased expression of BAR-1. Similarly, molecules like 6-Bromoindirubin-3'-oxime (BIO) and CHIR99021 act as GSK-3β inhibitors and thereby may upregulate the expression of BAR-1. Other compounds such as IWR-1 and XAV939 operate upstream in the Wnt pathway by stabilizing Axin, a part of the destruction complex that regulates β-catenin levels, thus augmenting the presence of BAR-1. Compounds like SkQ1 and JW55 may also induce the expression of BAR-1 through their roles in modulating mitochondrial functions and inhibiting tankyrase, respectively. Each of these compounds, among others, contributes to the complex regulatory network that determines the expression levels of BAR-1, highlighting the intricate web of interactions that sustain cellular function and organismal development.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit glycogen synthase kinase-3 beta (GSK-3β), leading to an accumulation of β-catenin homologs such as BAR-1 by preventing their proteasomal degradation. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
GSK-3 Inhibitor IX directly inhibits GSK-3β, which could lead to the stabilization and accumulation of BAR-1, thereby promoting its expression due to reduced proteolytic turnover. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
GSK-3 Inhibitor XVI selectively inactivates GSK-3β, which could result in the enhanced nuclear presence of β-catenin homologs and stimulate the transcription of Wnt target genes including that encoding for BAR-1. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $132.00 | 19 | |
IWR-1-endo prevents the aggregation of the Axin complex, leading to an upsurge in free β-catenin levels and potentially fostering increased expression of genes downstream of the Wnt pathway, such as BAR-1. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $94.00 $286.00 | 27 | |
By inhibiting the production of Wnt proteins, IWP-2 may cause an upregulation of compensatory mechanisms within the cell that could lead to an increase in BAR-1 expression through feedback loops. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $138.00 $595.00 | ||
QS11 disrupts ARF-GAP activity, which could lead to alterations in Wnt signaling dynamics, resulting in the transcriptional activation and upsurge of proteins in the β-catenin family, possibly including BAR-1. | ||||||
β-Catenin/Tcf Inhibitor, FH535 | 108409-83-2 | sc-221398 sc-221398A | 10 mg 50 mg | $178.00 $367.00 | 7 | |
FH535 inhibits both Wnt/β-catenin and PPAR signaling pathways, which could stimulate a compensatory increase in BAR-1 expression as the cell attempts to restore Wnt signaling homeostasis. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
By inhibiting tankyrase, XAV939 stabilizes Axin and constrains the degradation of β-catenin, potentially leading to an upsurge in nuclear β-catenin and the subsequent transcriptional increase of BAR-1. | ||||||
Cardamonin | 19309-14-9 | sc-293984 sc-293984A | 10 mg 50 mg | $220.00 $922.00 | ||
Cardamonin targets Wnt/β-catenin signaling at a transcriptional level, which could lead to a compensatory transcriptional response that upregulates the expression of β-catenin-related proteins such as BAR-1. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
Niclosamide closes down the canonical Wnt/β-catenin pathway, which might trigger the cell to induce the expression of BAR-1 as a feedback mechanism to reactivate the pathway. |